Vanadium(IV/V) complexes of Triapine and related thiosemicarbazones: synthesis, solution equilibrium and bioactivity by Kowol, Christian R. et al.
Journal of Inorganic Biochemistry 152 (2015) 62–73
Contents lists available at ScienceDirect
Journal of Inorganic Biochemistry
j ourna l homepage: www.e lsev ie r .com/ locate / j inorgb ioVanadium(IV/V) complexes of Triapine and related thiosemicarbazones:
Synthesis, solution equilibrium and bioactivityChristian R. Kowol a,b,⁎, Nóra V. Nagy c, Tamás Jakusch d, Alexander Roller a, Petra Heffeter b,e,
Bernhard K. Keppler a,b, Éva A. Enyedy d,⁎
a University of Vienna, Institute of Inorganic Chemistry, Währinger Strasse 42, A-1090 Vienna, Austria
b Research Platform “Translational Cancer Therapy Research” University of Vienna, Waehringer Strasse 42, A-1090 Vienna, Austria
c Institute of Organic Chemistry, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Magyar Tudósok körútja 2, H-1117 Budapest, Hungary
d Department of Inorganic and Analytical Chemistry, University of Szeged, H-6720 Szeged, Hungary
e Institute of Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria⁎ Corresponding authors.
E-mail addresses: christian.kowol@univie.ac.at (C.R. K
enyedy@chem.u-szeged.hu (É.A. Enyedy).
http://dx.doi.org/10.1016/j.jinorgbio.2015.08.023
0162-0134/© 2015 Elsevier Inc. All rights reserved.a b s t r a c ta r t i c l e i n f oArticle history:
Received 11 June 2015
Received in revised form 29 July 2015
Accepted 24 August 2015
Available online 1 September 2015
Keywords:
Equilibria
Cytotoxicity
Stability constants
X-ray crystal structure
EPR spectroscopyThe stoichiometry and thermodynamic stability of vanadium(IV/V) complexes of Triapine and two related
α(N)-heterocyclic thiosemicarbazones (TSCs) with potential antitumor activity have been determined by
pH-potentiometry, EPR and 51V NMR spectroscopy in 30% (w/w) dimethyl sulfoxide/water solvent mixtures.
In all cases, mono-ligand complexes in different protonation stateswere identiﬁed. Dimethylation of the terminal
amino group resulted in the formation of vanadium(IV/V) complexes with considerably higher stability. Three of
themost stable complexeswere also synthesized in solid state and comprehensively characterized. The biological
evaluation of the synthesized vanadium complexes in comparison to the metal-free ligands in different human
cancer cell lines revealed only minimal inﬂuence of the metal ion. Thus, in addition the coordination ability of
salicylaldehyde thiosemicarbazone (STSC) to vanadium(IV/V) ions was investigated. The exchange of the
pyridine nitrogen of the α(N)-heterocyclic TSCs to a phenolate oxygen in STSC signiﬁcantly increased the
stability of the complexes in solution. Finally, this also resulted in increased cytotoxicity activity of a
vanadium(V) complex of STSC compared to the metal-free ligand.
© 2015 Elsevier Inc. All rights reserved.1. Introduction
Thiosemicarbazones (TSCs) are Schiff bases obtained by condensa-
tion of an aldehyde or a ketone with a thiosemicarbazide and represent
an important class of (N,S) donor ligands [1]. TSCs and their metal com-
plexes are extensively investigated as they exhibit awide range of phar-
macologically interesting properties like anticancer, antibacterial,
antiparasitic, and antiviral effects [2]. Especially α(N)-heterocyclic
TSCs exert signiﬁcant antitumor activity in vitro and in vivo [2,3].
Triapine (3-aminopyridine-2-carbaldehyde thiosemicarbazone, 3-AP,
Chart 1) is the most prominent representative among the α(N)-pyridyl
TSCs since it has already been tested inmany phase I and II clinical trials
[4]. The proposedmechanism of action of Triapine is based on its ability
to inhibit the iron-dependent enzyme ribonucleotide reductase, the
rate-determining enzyme in the supply of deoxyribonucleotides for
DNA synthesis and repair [3,5]. It has been assumed that the formation
of an intracellular iron complex of Triapine plays a crucial role in the
mechanism of enzyme inhibition [6]. In this complex, Triapine acts asowol),tridentate ligand and coordinates via an (Npyr,N,S−) donor set, wherein
the hydrazinic-N moiety is deprotonated [3]. In general, this arrange-
ment of the donor atoms for α(N)-pyridyl TSCs is also suitable for the
binding of other transition metal ions, e.g. Cu(II), Zn(II), Ru(III), Pt(II),
and Pd(II), which can result in complexes with even higher cytotoxicity
than that of themetal-free ligands [2]. In our previousworkswe pointed
out that dimethylation of the terminal nitrogen strongly enhances the
cytotoxicity of α(N)-pyridyl TSCs, especially in the absence of any NH2
group in the molecule [7]. In addition, terminal dimethylation results
in a strong increase of the solution stability of the Fe(II/III), Cu(II),
Zn(II), and Ga(III) complexes [7–9]. The best-known terminally
dimethylated bis-pyridyl TSC is di-2-pyridylketone-4,4-dimethyl-3-
thiosemicarbazone (Dp44mT), which demonstrated very potent anti-
cancer activity in vivo using human xenografts in nude mice [10,11]
andwas reported to overcomemultidrug-resistance in cancer cells [12].
In addition, to the effects of the free ligands, also a wide range of
metal complexes of tridentate TSCs with remarkable biological effect
has been reported in the literature including copper [13–15], platinum
[16], or vanadiumcompounds [2,17,18].With regard to vanadium, com-
plexes of α(N)-pyridyl TSCs formed with oxovanadium(IV) and
dioxovanadium(V) were found to exert antibacterial, antifungal as
well as antiamoebic activity [17–20]. In addition, insulin-enhancing
Chart 1. Ligands used in this study: Triapine (3-AP) = 3-aminopyridine-2-
carboxaldehyde thiosemicarbazone; APTSC = 3-aminopyridine-2-carboxaldehyde
N,N-dimethylthiosemicarbazone; PTSC = pyridine-2-carboxaldehyde
N,N-dimethylthiosemicarbazone; STSC = salicylaldehyde thiosemicarbazone.
Chart 2. Tautomerism of thiosemicarbazones.
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However, the antitumor properties of α(N)-pyridyl TSC vanadium
complexes have, to the best of our knowledge, not been investigated
so far. Moreover, despite the fact that a relatively large number of
vanadium(IV/V) complexes of TSCs has been synthesized and char-
acterized in the solid state or in solution with organic solvents
[19–24], almost no information is available on their complex forma-
tion processes and thermodynamic stability in aqueous solution.
Notwithstanding, the knowledge of the speciation and the most
feasible chemical forms of a biologically active metal complex in aque-
ous solution, especially at physiological pH, can help to understand
the mechanism of action and might be useful for the design of more
effective and selective chemotherapeutics. Thus, the main aims of the
present work were to perform a detailed solution equilibrium
study on the vanadium(IV/V) complexes of Triapine and two terminally
dimethylated derivatives (Chart 1, 3-aminopyridine-2-carboxaldehyde
N,N-dimethylthiosemicarbazone (APTSC) andpyridine-2-carboxaldehyde
N,N-dimethylthiosemicarbazone (PTSC)), and to screen their cyto-
toxicity against human cancer cell lines. Therefore, various methods
such as pH-potentiometry, UV–vis spectrophotometry as well as
electron paramagnetic resonance (EPR) and 51V NMR spectroscopy
were used to investigate the stoichiometry and stability of the com-
plexes in solution. Additionally, several vanadium complexes were
synthesized and subsequently characterized by means of 1H, 13C,
and 51V NMR spectroscopy as well as X-ray diffraction studies. Finally,
the obtained solution speciation data of the vanadium(IV/V) com-
plexes formed with α(N)-pyridyl TSCs were compared to that ofTable 1
Proton dissociation constants (pKa) and logD7.4 values of the studied TSC ligands aswell as overall
I= 0.10 M (KCl) in 30% (w/w) DMSO/H2O}.a
Triapine APTSC
pK1 3.92b 4.31b
pK2 10.78b 10.29
logD7.4 +0.85c +1.30
logβ [V(IV)O(LH)] – –
logβ [V(IV)O(L)] 8.50(8) 10.30(
logβ [V(IV)O(L)H−1] 3.21(9) 4.14(1
pK [V(IV)O(L)] 5.29 6.16
Fitting parameter (mL) 4.90 × 10−3 3.25 ×
logK′ [V(IV)O(L)]d 7.23 8.67
Predominant complexe ([V(IV)O2(OH)5]) [V(IV)
a Uncertainties (SD) of the last digits are shown in parentheses determined for the TSCs stu
b Taken from [8].
c Taken from [25].
d Conditional stability constants at pH= 7.4; Κ′= β [V(IV)O(L)] × (1 + β [V(IV)O(L)H−1]
e At pH= 7.4; cV(IV)O = 1.0 mM; V(IV)O:L = 1:1.salicylaldehyde thiosemicarbazone (STSC, Chart 1) complexes with
an (O−,N,S−) donor set.
2. Results and discussion
2.1. Solution chemistry of vanadium(IV/V) complexes of Triapine, APTSC,
and PTSC
2.1.1. pKa values and lipophilicity of the ligands
The proton dissociation constants (pKa) of Triapine, APTSC and PTSC
(Table 1) in a 30% (w/w) DMSO/H2O solvent mixture were already de-
termined in our previous work by pH-potentiometric, UV–vis, and 1H
NMR titrations [8]. In accordance to these data, the repetitive measure-
ments in this study provided similar values. Noteworthy, the presence
of DMSO was required due to the limited water solubility of the ligands
as well as their respective vanadium complexes. The obtained pK1 can
be attributed to the proton dissociation of the pyridinium unit and pK2
values to the deprotonation of the hydrazinic NH group of the
thiosemicarbazide moiety. In the latter proton dissociation step, the
resulting negative charge is mainly localized on the S atom via the
thione–thiol tautomeric equilibrium (Chart 2) [8]. Based on the pKa
values, it can be concluded that all three α-pyridyl TSCs are present in
their neutral HL form at pH 7.4.
In order to characterize the lipophilic character of the ligands, distri-
bution coefﬁcients of APTSC and PTSC were determined by the tradi-
tional shake ﬂask method at pH 7.4 (logD7.4 values in Table 1), which
represent the actual partitioning between n-octanol and water. As ex-
pected, the methyl groups on the terminal nitrogen of the α-pyridyl
TSCs increase the logD7.4 value compared to that of the reference
compound Triapine [25].
2.1.2. Complex formation equilibria of vanadium(IV) with Triapine, APTSC,
and PTSC
The complex formation processes of Triapine, APTSC, and PTSC with
V(IV)O were studied by the combined approach of pH-potentiometry,
UV–vis spectrophotometry, and EPR spectroscopy in a 30% (w/w) DMSO/
H2O solvent mixture under anaerobic conditions. The stoichiometries of(logβ), stepwise and conditional stability constants for their V(IV)O complexes {T=25.0 °C,
PTSC STSC
3.38b 8.89c
b 10.54b 12.59c
(8) +1.11(15) +1.74c
– 20.55(2)
4) 10.83(2) 16.67(1)
2) 4.74(5) 9.79(1)
6.09 6.88
10−3 2.90 × 10−3 3.08 × 10−3
9.02 10.61
O(LH−1)] [V(IV)O(LH−1)] [V(IV)O(LH−1)]
died in the present work. Charges of the metal complexes are omitted for clarity.
/ [H+] / β [V(IV)O(L)]) / (1 + [H+] × βHL + [H+]2 × βH2L).
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culated on the basis of the pH-potentiometric titrations are listed in
Table 1. These studies revealed the formation of mono-ligand com-
plexes such as [V(IV)O(L)]+ and [V(IV)O(L)H−1]. Although, other biva-
lent metal ions (e.g. Zn(II) and Fe(II)) form [M(LH)]2+ species as well
[8], stability constants for this kind of V(IV)O complexes could not be
calculated with appropriate accuracy. Complexation of Triapine with
V(IV)O starts only at pH N 4 and the ligand is not able to protect the
metal ion against the hydrolysis at a metal-to-ligand ratio of 1:1 at
pH N 6 in the 1 mM concentration range resulting in precipitation.
Notably, a maximum of 20% of V(IV)O is bound to Triapine (at
pH ~ 5 under this condition) representing a quite weak metal-binding
ability of this ligand (Fig. 1a). On the contrary, complex formationFig. 1. Representative concentration distribution diagrams for V(IV)O complexes formed
in the V(IV)O — Triapine (a), APTSC (b) and PTSC (c) systems plotted against the pH
calculated on the basis of the pH-potentiometric results. {V(IV)O:L = 1:1; cligand =
2.0 mM; T= 25.0 °C, I = 0.10 M (KCl) in 30% (w/w) DMSO/H2O}. Dashed lines indicate
the pH range where signiﬁcant amounts of hydrolyzed V(IV)O species are formed.processes with the terminally dimethylated ligands (PTSC and APTSC)
start at lower pH values (pH ~ 2–2.5) indicating species of higher stabil-
ity. In addition, the bound fraction of oxovanadium(IV) exceeds 90% at
pH ~ 5.2 and 4.5 in the V(IV)O–APTSC and PTSC systems, respectively
(Fig. 1b and c). Complex formation in the V(IV)O–PTSC system was
also monitored by UV–vis spectrophotometric titrations. Instead of
the rather weak d–d transition bands of the complexes, the pH-
dependence of the overlapping charge-transfer (CT) and ligand bands
was followed. Differences between the absorbance values recorded in
the presence and in the absence of the V(IV)O ions undoubtedly reveal
the pH ranges of the complex formation followed by dissociation. This
corresponds well to the expectations based on the concentration distri-
bution curves calculated with the aid of the stability constants (Fig. S1).
In order to elucidate the actual coordination modes in solution and
conﬁrm the speciationmodel obtained by pH-potentiometry, EPR spec-
tra were recorded at various pH values at room temperature (Fig. 2). In
case of the V(IV)O–PTSC system, spectra could be recorded up to pH 9.8
using individual samples. In contrast, when titrations were performed
with Triapine and APTSC, oxidation took place resulting in the continu-
ous loss of the EPR signal at higher pH values, although the measure-
ments were done under an argon atmosphere (but not under strictly
anaerobic conditions). It is noteworthy, that the hydrolysis of the
metal ion can strongly increase the sensitivity to oxidation. The two-
dimensional simulation of the solution EPR spectra resulted in the indi-
vidual isotropic EPR spectra (Fig. 2) and the isotropic EPR parameters of
V(IV)O and the complexes [V(IV)O(L)]+ and [V(IV)O(L)H−1] (Table 2).
Therewas no indication for the formation of EPR-active dinuclear or bis-
ligand complexes. Similar g0 and A0 values were obtained for all
[V(IV)O(L)]+ complexes of the different α-pyridyl TSCs, in which the
tridentate coordination of the ligands via the (Npyr,N2,S−) donor set
is the most probable and where the ligand possesses a deprotonated
hydrazinic moiety. In comparison, formation of isomers and somewhat
higher A0 parameters (94.7 × 10−4 cm−1 and 101 × 10−4 cm−1) were
reported for chlorido V(IV)O-thiosemicarbazone complexes in a non-
aqueous solvent [26]. Complexes [V(IV)O(L)H−1] have higher g0 values
and lowerA0 values compared to those of [V(IV)O(L)]+ indicating an in-
creased ligand ﬁeld due to the deprotonation of the coordinated water
molecule. As a consequence, [V(IV)O(L)H−1] complexes are considered
asmixed hydroxido species [V(IV)O(L)(OH)]. Using the empirical addi-
tivity relationship [27,28], the average A0 value of the contribution of a
thiolate, two aromatic nitrogen atoms (no data for imine-N) and a
water molecule is 87.0 × 10−4 cm−1 and for the mixed hydroxido spe-
cies 80.6 × 10−4 cm−1. All estimations are in good agreement with the
measured data in Table 2.
In the case of the V(IV)O–PTSC system, EPR spectrawere also record-
ed on frozen samples at 77 K. The calculated anisotropic EPR parameters
(Table 3) and the spectra simulation for the [V(IV)O(L)]+ and
[V(IV)O(L)H−1] species (Fig. 3) permitted the conclusion that most
probably two kinds of isomers with a molar ratio of ~1:6 are formed
under these conditions. The isotropic EPR parameters of the major iso-
mers (1) calculated by averaging the anisotropic values (g0,calc and
A0,calc in Table 3) are similar to those of the datameasured at room tem-
perature showing that the structure of the complexes [V(IV)O(L)]+ and
[V(IV)O(L)H−1] did not change during freezing. On the other hand, the
minor isomers (2) have fairly different anisotropic EPR parameters,
which can be possibly explained by the octahedral “trans” (H2O: axial,
PTSC: equatorial, equatorial, equatorial, H2O/OH− equatorial) penta-
coordinated square pyramidal or octahedral “trans” – octahedral “cis”
(H2O: equatorial, PTSC: equatorial, axial, equatorial, H2O/OH− equatori-
al) – isomerism [29]. This is quite frequent in the case of V(IV)O species
and was also observed for other V(IV)O–TSC complexes [24,26]. In the
protonation state of VO(IV)L the octahedral “trans”, while in the case
of complex [V(IV)OL(OH)] the penta-coordinated/octahedral “cis”
forms are the most stable species.
Direct comparison of stability constants and concentration distribu-
tion curves calculated for the V(IV)O complexes formed with the
Fig. 2. Experimental (black) and simulated (red) isotropic EPR spectra recorded for theV(IV)O— Triapine (a), APTSC (b) and PTSC (c) systems togetherwith the calculated component EPR
spectra of the various species. Spectral intensities have been normalized for better comparison. {cligand= 1.0 mM; V(IV)O:L= 1:2, 1:2 and 1:4 for APTSC, PTSC and Triapine, respectively;
T= 25.0 °C, I= 0.10 M (KCl) in 30% (w/w) DMSO/H2O}.
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form stable complexes with V(IV)O even at mM concentrations. In con-
trast, the complex stability of terminally dimethylated TSCs is distinctly
increased. This is in good agreement with previous studies from our
group on other metal ions [8,9].2.1.3. Complex formation equilibria of vanadium(V) with Triapine, APTSC,
and PTSC
As a next step, the V(V)-binding abilities of Triapine, APTSC, and
PTSC were studied by 51V NMR spectroscopy. This method provides an
excellent possibility to distinguish between the free V(V) species (in
monomeric or different oligomeric forms) and V(V) complexes due to
the slow ligand-exchange process with respect to the NMR time scale.
Therefore, signals of bound and free metal ions can be seen separately
(as an example, PTSC is shown in Fig. 4a). However, species with the
same metal-to-ligand ratio in different protonation states represent
fast exchange processes. Thus, their signals are only shifted upon the
(de)protonation processes. First of all, complex formation was followed
at pH 7.4 in the 1.0 mM concentration range. No bound V(V) fractions
were found in the case of Triapine as a consequence of the quite low
vanadate afﬁnity of this ligand. Accordingly, further measurements
were only performed for APTSC and PTSC.
51VNMR spectrawere recorded in the pH range 11.2–~1.6 by the ad-
dition of strong acid to the samples, although an irreversible process
was observed at pH b 5 and the intensities of the peaks were stronglyTable 2
Isotropic EPR parameters obtained for the V(IV)O–TSC complexes calculated from the
two-dimensional simulation of EPR spectra {T= 25.0 °C, I= 0.10 M (KCl) in 30% (w/w)
DMSO/H2O}.a
Ligand Species g0 A0/×10−4 cm−1 α/G β/G γ/G
– V(IV)O2+ 1.9616(2) 104.5(2) 18.7(1) 3.5(1) 1.8(1)
Triapine [V(IV)O(L)]+ 1.9703(8) 87.8(8) 23(2) 5(1) 2.8(3)
Triapine [V(IV)O(L)H−1] 1.972(2) 82.9(4) 26(7) 3(2) 3(1)
APTSC [V(IV)O(L)]+ 1.9709(9) 87.4(1) 23(3) 5(2) 3.3(1)
APTSC [V(IV)O(L)H−1] 1.971(2) 79.1(3) 26(7) 3(2) 3(1)
PTSC [V(IV)O(L)]+ 1.9702(2) 88.7(6) 19(3) 4(1) 2.3(5)
PTSC [V(IV)O(L)H−1] 1.9711(4) 83.1(6) 19(7) 3(2) 2(1)
STSC [V(IV)O(L)] 1.9717(7) 87.6(7) 21(1) 3(1) 2.0(3)
a Uncertainties (SD) of the last digits are shown in parentheses determined in the
present work.diminished. Most probably V(V) is able to oxidize APTSC and PTSC in
this pH range with simultaneous formation of paramagnetic V(VI)O. In-
terestingly, a similar redox reaction was already described for Fe(III)
complexes of α(N)-pyridyl TSCs, however only at pH N 10 [9,30]. Solely
peaks of the non-bound V(V) species could be observed at pH N ~10, in
the case of PTSC (Fig. 4a) andAPTSC,mainly in a form of HVO42−. Forma-
tion of [V(V)O2(L)] was further investigatedwith decreasing pH and the
position of its signal in the NMR spectra did not change down to pH ~ 5.
In this complex, most probably coordination of two oxo groups and the
deprotonated ligand through the (Npyr,N2,S−) donor atoms results in a
distorted square-pyramidal geometry (Chart 3). This coordination
mode was also conﬁrmed by X-ray crystal structure analysis of solid
V(V)–PTSC and V(V)–APTSC complexes (Section 2.2). Subsequently,
the distribution of V(V) between bound and unbound fractions at a
1:1 metal-to-ligand ratio was calculated on the basis of the integrated
area of the peaks for the V(V)–PTSC and APTSC systems (Fig. 4b).
From these values, stability constants were computed for the formation
of [V(V)O2(L)] complexes (see Table 4 for the equilibriumprocesses and
constants). The bound V(V) fraction is slightly higher for PTSC com-
pared to APTSC (91% vs. 82%), and the boundmetal ion fraction is higher
in the case of the V(V)-containing systems compared to V(IV)O
representing a somewhat higher stability of the V(V) complexes.
2.2. Synthesis and characterization of vanadium(IV/V) complexes of PTSC
and APTSC
As a result of the solution equilibrium studies, it was concluded that
Triapine is not an efﬁcient chelator for vanadium(IV/V) ions. Therefore,
we prepared only the vanadium complexes of the terminally
dimethylated ligands (PTSC and APTSC) for further biological studies.
The twometal-free ligands APTSC and PTSCwere synthesized according
to literature [7,31]. The V(V)O2-containing complexeswere synthesized
in methanol in 1:2 molar ratio using the appropriate TSC ligand (HL)
and the vanadium(V) precursor V2O4(acac)2 (where acac = acetylace-
tonate) [32]. This resulted in formation of the orange and red
[V(V)O2(L)] complexes of PTSC (1a) and APTSC (1b), respectively, in
good yields (Chart 3). The green oxovanadium(IV) complex
[V(IV)O(L)(acac)] of PTSC (2a) (Chart 3) was synthesized in ethanol
in 78% yield using VO(acac)2 and the ligand in a 1:1 molar ratio.
The 1H NMR spectrum of the V(V)O2 complexes conﬁrmed depro-
tonation of the TSC ligands by the absence of the NH proton signal of
Table 3
Anisotropic EPR parameters obtained for the V(IV)O–PTSC complexes {T= 77 K, I= 0.10 M (KCl) in 30% (w/w) DMSO/H2O}.a
gǀǀ g┴ Aǁ/×10−4 cm−1 A┴/×10−4 cm−1 go,calcb Ao,calc c/×10−4 cm−1
V(IV)O2+ 1.9325 1.9743 179.7 67.5 1.9604 104.9
[V(IV)O(L)]+ (1) 1.9525 1.9801 158.2 54.4 1.9709 89.0
[V(IV)O(L)]+ (2) 1.9470 1.9788 164.5 59.6 1.9672 94.6
[V(IV)O(L)H−1] (1) 1.9546 1.9801 153.6 50.5 1.9716 84.9
[V(IV)O(L)H−1] (2) 1.9683 1.9823 143.6 45.6 1.9776 78.3
a The experimental error was ±0.001 for gǀǀ, ±0.0005 for g┴, ±0.5 × 10−4 cm−1 for Aǁ, and ± 0.2 × 10−4 cm−1 for A┴.
b g0,calc = (gǀǀ + 2 g┴) / 3.
c A0,calc = (Aǀǀ + 2A┴) / 3.
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free PTSC, which shows two isomeric forms [33] in DMSO-d6, the
V(V)O2 complexes possess only one set of signals in the 1HNMR spectra.
This can be explained by stabilization of the ligand conﬁguration upon
coordination to the metal center. The 51V NMR shifts of 1a at−427.5
and 1b at −430.0 ppm measured in DMSO-d6 were in the expected
range of this type of vanadium complexes [21].
Single crystals of X-ray diffraction quality of 1a were obtained after
several days directly from the mother liquor. In contrast, crystals of 2a
were produced by slow diffusion of ether into a solution of the complex
in CH2Cl2 under argon atmosphere. Crystal data, data collection param-
eters, and structure reﬁnement details are given in Table S1. The results
of the X-ray diffraction studies are shown in Fig. 5 and selected bond
distances and angles are summarized in Table 5 for 1a and 2a in com-
parison to the PTSC ligand [7]. For the vanadium(V) complex 1a
(Fig. 5), the coordination polyhedron around themetal ion is intermedi-
ate between square-pyramidal and trigonal-bipyramidal with τ= 0.37
(τ= 1 for an ideal trigonal bipyramid, τ= 0 for an ideal square pyra-
mid) [34]. The vanadium(V) is coordinated by one tridentate
deprotonated PTSC ligand (L−) via the pyridine nitrogen atom as well
as the nitrogen and sulfur donors of the thiosemicarbazide moiety and
two oxido ligands with bond length in the expected range for such
type of complexes [21,24].
In contrast, in the oxovanadium(IV) complex 2a, the coordination
polyhedron approaches an octahedron, where one tridentate PTSC, a
bidentate acac, and an oxido ligand is coordinated to the metal center
(Fig. 5). Comparably to complex 1a, the ligand is deprotonated (L−).Fig. 3. Calculated component anisotropic EPR spectra of V(IV)O and various isomeric
species formed in the V(IV)O–PTSC system. {T = 77 K, I = 0.10 M (KCl) in 30% (w/w)
DMSO/H2O}.Of note is the difference in the bond length from vanadium(IV) to the
acac oxygen atoms with V–O1 at 1.984 Å and V–O2 at 2.155 Å. The
enlongated bond length of V–O2 can be explained by the trans inﬂuence
of the oxido ligand and is in agreement with a similar structure with
2-acetylpyridine-4-phenylthiosemicarbazone [35]. In crystal structures
of both, 1a and 2a, deprotonation of the PTSC ligand is accompanied
with a distinct elongation of the C7–S bond (1a: 1.737 Å; 2a: 1.751 Å)
compared to the metal-free ligand at 1.686 Å indicating an increased
single-bond character [7]. In addition, the C7–N3 bond decreases from
1.373 Å to 1.325 Å in 1a and 1.334 Å in 2a, respectively.2.3. Cytotoxicity of complexes 1a, 1b, and 2a
As a next step, the cytotoxicity of the novel synthesized compounds
(IC50 values in nM) of 1a, 1b, and 2a in comparison to their metal-free
ligands was measured in three human cancer cell lines (colon carcino-
ma SW480, ovarian carcinoma A2780, and epidermal carcinoma-
derived KB-3-1 cells). Table 6 shows the IC50 values for the compounds
after 72 h incubation measured by the 3-(4,5-dimethyl-2-thiazolyl)-
2,5-diphenyl-2H-tetrazolium bromide (MTT) assay.
In general, A2780 cells were found to be themost sensitive of the in-
vestigated cell lines, whereas SW480 and KB-3-1 cells were less affected
by the compounds. In accordance to the literature, PTSC had IC50 values
in the (low) nanomolar range, whereas, APTSC was active at low μM
concentrations comparable to Triapine [7]. Interestingly, the sensitivity
proﬁle of SW480 cells was strongly different from KB-3-1 and A2780.
These two cell models were very sensitive towards PTSC and its com-
plexes, while in SW480 cells a distinctly reduced activity was observed.
In contrast, APTSC and its vanadium complex showed quite similar ac-
tivity in all three cell lines. This probably originates from differences in
the mode of action, which were observed for PTSC compared to APTSC
[36]. Despite these differences originating from the ligand properties,
the impact of vanadium complexation was rather weak. Thus, only in
KB-3-1 cells a non-signiﬁcant tendency for increased activity of 1a and
2a in comparison to the respective free ligandwas observed. In contrast,
1bwas slightly less active than APTSC in all tested cell lines. This lack of
impact canmost probably be explained by the release of the ligands due
to the low solution stability of these vanadium complexes already in the
low micro- to nanomolar concentration range.Chart 3. Structures of the synthesized complexes 1a (R1 = H), 1b (R1 = NH2) and 2a.
Fig. 4. 51VNMR spectra recorded for the V(V)–PTSC system at various pHvalues (a) andmolar fractions of the non-bound vanadate (as the sumof the fractions ofHVO42−/H2VO4−/HV2O73−/
H2V2O72−/V4O124−; empty circles) and bound V(V) (ﬁlled circles) for PTSC (black symbols) and APTSC (gray symbols) from the integrated area of the 51V NMR signals (b). {cV(V)= 1.0mM;
V(V):L = 1:1; T= 25.0 °C, I= 0.10 M (KCl) in 30% (v/v) DMSO, 60% (v/v) H2O, 10% (v/v) D2O}.
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studies
In order to investigate whether the solution stability of
vanadium(IV/V) complexes of tridentate thiosemicarbazones and
their cytotoxicity can be increased by exchange of the pyridyl nitrogen
for a harder Lewis acid donor atomwith higher afﬁnity to the vanadium
ions, STSC with a phenolate oxygen was chosen as a test compound
(Chart 1).
The acid–base properties of STSC have already been studied in detail
in our previous work [25], and the pKa values determined here are in
good agreement with the published data (Table 1). The pK1 and pK2
values of the ligand can be attributed to deprotonation of the phenolic
OHgroup aswell as the hydrazinic-NHof the thiosemicarbazidemoiety.
Noteworthy, the proton dissociation constant of the azomethine nitro-
gen atom (pK2) of STSC is signiﬁcantly higher compared to that of the
α(N)-pyridyl TSCs. This can be explained by the different total charge
of the ligands in the mono-protonated form: the α(N)-pyridyl TSCs
are neutral, while STSC has one negative charge. It was found that
STSC is mainly present in the neutral form (96% H2L; 4% HL−) at
physiological pH and its logD7.4 value [25] is considerably higher
compared to those of the α(N)-pyridyl TSCs (Table 1).
The V(IV)O-binding ability of STSC was studied by pH-
potentiometry and EPR methods. The pH-potentiometric data revealTable 4
Stability and protonation constants determined for the species formed in the V(V)O2–TSC
systems and their chemical shifts (δ (51V)) {T = 25.0 °C, I = 0.10 M (KCl) in 30% (v/v)
DMSO, 60% (v/v) H2O, 10% (v/v) D2O}.a
Ligand Equilibrium Constant
– HVO42−+ H+⇌ H2VO4−
−561 ppm−536 ppm
logK= 9.36(2)
APTSC H2VO4−+ HL + H+⇌ [VO2(L)] + 2 H2O
−416 ppm
logΚ= 3.08(3)
PTSC H2VO4−+ HL + H+⇌ [VO2(L)] + 2 H2O
−421 ppm
logΚ= 3.34(3)
STSC [VO2(L)]− (1) + H+⇌ [VO2(LH)]
−449 ppm−502 ppm
logK= 3.56(1)
STSC [VO2(L)H−1]2−+ H+⇌ [VO2(L)]− (2)
−539 ppm−577 ppm
logK= 9.95(2)
STSC H2VO4−+ H2L⇌ [VO2(L)]− (1) + 2 H2O logΚ= 5.42(5)
STSC H2VO4−+ H2L⇌ [VO2(L)]− (2) + 2 H2O logΚ= 4.57(5)
a Uncertainties (SD) of the last digits are shown in parentheses.the formation of mono-ligand species: [V(IV)O(LH)]+, [V(IV)O(L)] as
well as [V(IV)O(L)H−1]− comparably to previous data on complexes
formed with other bivalent metal ions such as Cu(II) and Zn(II) [12].
Overall stability constants of the V(IV)O-STSC complexes are summa-
rized in Table 1. Based on the deconvolution of the EPR spectra recorded
at room temperature, a component spectrum (Fig. 6a) and isotropic EPR
parameters (Table 2) of the complex [V(IV)O(L)] could be calculated.
Notably, data for [V(IV)O(LH)]+ and [V(IV)O(L)H−1]− could not be ob-
tainedwith proper accuracy. This ismost probably due to the lowmolar
fraction of the protonated complex and the partial oxidation process in
the pH range of the formation of [V(IV)O(L)H−1]−. Notably, the g0 value
of [V(IV)O(L)] is slightly higher, although A0 is in the same range, com-
pared to the parameters of the corresponding complexes of Triapine,
APTSC, and PTSC. It is noteworthy that the oxovanadium(IV) complex
of salicylaldehyde semicarbazone (SSC) with (O−,N,O−) binding mode
possesses signiﬁcantly different EPR parameters (g0 = 1.9674, A0 =
101.4 G / 93.1 × 10−4 cm−1) [37]. The most feasible binding mode in
the [V(IV)O(L)] complex of STSC is a coordination via the (O−,N,S−)
donor set together with a deprotonated hydrazine moiety. This is in
agreement with some X-ray crystal structures for ternary
oxovanadium(IV) complexes of STSC or its derivatives formed with
(N,N) bidentate aromatic co-ligands such as 1,10-phenanthroline or
2,2′-bipyridine in literature [23,38]. In the protonated [V(IV)O(LH)]+
species the ligand most likely coordinates via (O−,N,S) donor atoms
(with protonated NH group), while [V(IV)O(L)H−1]− is a mixed
hydroxido complex (=[V(IV)O(L)(OH)]−).
Due to the higher ligand basicity (higher pKa values) of STSC com-
pared to theα(N)-pyridyl TSCs, stronger ligand effectiveness is expect-
ed at higher pH values. Indeed, the increased oxovanadium(IV) binding
ability of STSC over theα(N)-pyridyl TSCs is clearly reﬂected in the con-
ditional stability constants (see logΚ′ values calculated at pH 7.4 in
Table 1) and the higher fractions of the bound metal ion in a broader
pH range including pH 7.4 (c.f. Figs. 6b and 1). Thus, the involvement
of the phenolate oxygen into the coordination instead of the pyridyl
nitrogen results in more favorable complex formation with V(IV)O.
Since no redox reaction was observed, the V(V)–STSC system could
be monitored over a wider pH range by 51V NMR spectroscopy
(Fig. 7a/b) compared to the α(N)-pyridyl TSCs. The recorded spectra
represented formation of isomeric species (1) and (2) and three groups
of signals were identiﬁed as follows: i) unbound V(V) as HV(V)O42− and
H2V(V)O4−; ii) bound V(V) as [V(V)O2(LH)] (1) and [V(V)O2(L)]− (1) as
well as iii) [V(V)O2(L)]− (2) and [V(V)O2(L)H−1]2− (2) (Fig. 7b). Based
on the pH-dependence of the chemical shifts of the peaks, equilibrium
Fig. 5.ORTEPviewof [V(V)O2(L)] complex of PTSC (1a) and [V(IV)O(L)(acac)] complex of PTSC (2a)with thermal ellipsoids at 50% probability level. Selected bond distances and angles are
summarized in Table 5.
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[V(V)2(L)]− (1) and [V(V)O2(L)H−1]2− (2) species (Table 4). For the
major isomer [V(V)O2(L)]− (1) formed between pH ~ 3 and ~11, our
data suggest ligand coordination most probably via the (O−,N2,S−)
donor set together with protonation of the N3 thiosemicarbazone nitro-
gen. This results in formation of [V(V)O2(LH)] (1) with an (O−,N2,S)-
binding mode, which is in agreement with literature reports on solid
phase structures for [V(V)O2(L)]− and [V(V)O2(LH)] of STSC
representing these coordination modes [22]. Based on the integrated
areas the ratio of major and minor isomers of [V(V)O2(L)]− is 6.4:1
and was detected at−449 ppm and−577 ppm, respectively. This sig-
niﬁcant difference between the two chemical shifts suggests that be-
sides the tridentate (O−,N2,S−)-binding mode also a rather different
coordination mode exists. In the case of the analogous semicarbazone,
SSC, a minor isomer was also found at a similar chemical shift
(−575.5 ppm) [37]. In this minor species, the chalcogen atom seems
to be non-coordinated and a (O−,N2,N4)-binding mode is feasible.
Notably, the [V(V)O2(L)]− (2) isomer has no protonated form but is
able to form a mixed hydroxide species [V(V)O2(L)H−1]2− (2) in the
basic pH range.
Representative concentration distributions curves are shown for the
V(V)–STSC system in Fig. 8 calculated with the aid of the determinedTable 5
Selected bond lengths, angles and torsions for 1a, 2a and PTSC.a
1a 2a PTSCb
V(IV)–O1 [Ǻ] 1.984(1)
V(IV)–O2 [Ǻ] 2.155(1)
V(IV)–O3 [Ǻ] 1.608(1)
V(V)–O1 [Ǻ] 1.608(2)
V(V)–O2 [Ǻ] 1.617(2)
V–S1 [Ǻ] 2.3725(8) 2.4026(6)
V–N1 [Ǻ] 2.105(2) 2.150(1)
V–N2 [Ǻ] 2.149(2) 2.074(1)
S1–C7 [Ǻ] 1.737(3) 1.751(2) 1.686(1)
N2–N3 [Ǻ] 1.355(3) 1.365(2) 1.359(1)
N2–C6 [Ǻ] 1.291(3) 1.294(2) 1.294(1)
N3–C7 [Ǻ] 1.325(3) 1.334(2) 1.373(1)
N4–C7 [Ǻ] 1.328(4) 1.341(2) 1.342(1)
C5–C6 [Ǻ] 1.439(4) 1.453(2) 1.466(2)
S–V–N2 [deg] 76.91(6) 79.08(4)
N1–V–N2 [deg] 74.67(8) 77.42(5)
S–V–N1 [deg] 151.38(7) 154.07(4)
N2–V–O1 [deg] 121.2(1) 163.89(5)
N2–V–O2 [deg] 129.1(1)
N1–V–O1 [deg] 97.3(1)
N1–V–O2 [deg] 97.4(1)
O2–V–O3 [deg] 171.86(5)
C6–N2–N3–C7 [deg] −178.7(2) −171.3(1) 177.6(1)
N2–N3–C7–S [deg] −0.2(3) 4.0(2) −4.9(1)
a Uncertainties (SD) of the last digits are shown in parentheses.
b Taken from [7].stability data (Table 4). It could be concluded that the species
[V(V)O2(L)]− (1) and (2) are predominant at neutral pH.
In order to compare the vanadium(IV/V) binding ability of the stud-
ied TSC ligands pM* values were also calculated at pH 7.4 (Table S2).
pM* is the negative logarithmof the summed equilibrium concentration
of the non-bound metal ion and its hydroxido species under the condi-
tions employed. According to these values the ligand effectiveness is for
both the V(IV)O and V(V) ions in the following order: Triapine b APTSC,
PTSC ≪ STSC. Thus, the solution equilibrium studies clearly revealed
that the exchange of the α-pyridyl nitrogen by a phenolate oxygen
indeed resulted in the formation of complexes with distinctly higher
stability. To investigate if this is also reﬂected in the biological activity,
a cytotoxicity test of the system with highest stability (V(V) with
STSC) was performed in analogy to the biological investigations of the
α-pyridyl TSCs above. In these experiments, metal-free STSC showed
hardly any activity with IC50 value of N100 μM in all three cell lines
(KB-3-1, SW480 and A2780 cells). In contrast, co-incubation of STSC
with NaVO3 in 1:1 ratio at pH 7.4 (with formation of [V(V)O2(L)]−)
was found to increase the cytotoxicity especially in A2780 cells to an
IC50 of 27.4 ± 8.2 μM (in the other two cell lines the IC50 value was
still N100 μM). In general, it is well known that STSC possesses signiﬁ-
cantly lower antiproliferative activity [39] compared to the class of
α(N)-pyridyl TSCs [7]. This can probably be explained by the fact that
α(N)-pyridyl TSCs were found to be unambiguously more efﬁcient
chelators for Fe(II) than STSC over a wide pH range [25]. This indicates
that in case of STSC the redox cycling of the intracellularly formed iron
complexes, which is assumed to be crucial for the activity of
thiosemicarbazones, is hampered [6].
3. Conclusions
In the presented study, stoichiometry and stability of vanadium(IV/V)
complexes formed with Triapine and two derivatives with
dimethylated terminal amino groups (APTSC and PTSC) were studied
in 30% (w/w) DMSO/H2O solvent mixture focusing on the most
plausible species emerging at physiological pH. Stability constantsTable 6
In vitro cytotoxicity (IC50 values in nM) of 1a, 1b, and 2a in comparison to their metal-free
ligands were measured in human cancer cell lines.
KB-3-1 SW480 A2780
1a 67 ± 37 N500 3.3 ± 9
2a 60 ± 34 330 ± 4 2.5 ± 4
PTSC 92 ± 5 310 ± 13 2.5 ± 3
1b 1000 ± 7 700 ± 4 600 ± 17
APTSC 750 ± 30 400 ± 3 340 ± 6
Triapine 2800 ± 20a 400 ± 50b N/A
a Taken from [36].
b Taken from [14].
Fig. 6. Experimental (black) and simulated (red) isotropic EPR spectra recorded for the V(IV)O–STSC system together with the calculated component EPR spectra of the various species
with normalized spectral intensities for better comparison (a), and representative concentration distribution diagrams for V(IV)O complexes formed in the same system plotted against
the pH calculated on the basis of the pH-potentiometric results (b) {cligand = 1.0 mM; V(IV)O:L = 1:1; T= 25.0 °C, I= 0.10 M (KCl) in 30% (w/w) DMSO/H2O}.
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pH-potentiometry and EPR in the case of the oxovanadium(IV) com-
plexes, while 51V NMR spectroscopy was applied as the main tool for
studying the complexation of vanadium(V). Formation of only
mono-ligand oxovanadium(IV) complexes such as [V(IV)O(L)]+ and
[V(IV)O(L)(OH)] was foundwith Triapine, APTSC, and PTSC. Here, coor-
dination of ligand most probably occurs in a tridentate mode via an
(Npyr,N,S−) donor set, while the hydrazinic-N is deprotonated. Triapine
was found to be an inefﬁcient oxovanadium(IV) binder at neutral pH,Fig. 7. 51V NMR spectra recorded for the V(V)–STSC system at various pH values (a) and chem
[V(V)O2L]− (1) + H+; ○: [H2V(V)O4]−⇌ [HV(V)O4]2−+ H+; □: [V(V)O2L]− (2)⇌ [V(V)O2
(v/v) DMSO, 60% (v/v) H2O, 10% (v/v) D2O}.whereas the terminally dimethylation results in an enhancement of
the complex stability. This is also true for V(V): Triapine was not able
to bind V(V) at pH 7.4, whereas APTSC and PTSC form [V(V)O2(L)]
type complexes, which possessed even somewhat higher stabilities
than the oxovanadium(IV) species.
Subsequently, vanadium complexes of PTSC and APTSC with ade-
quate stability at physiological pH were synthesized and in detail char-
acterized followed by cell culture tests in human cancer cell lines.
Overall, the vanadium complexes exhibited widely identical anticancerical shifts of the various groups of species plotted against the pH (b). ◊: [V(V)O2LH]⇌
L(OH)]2−+ H+. {cV(V) = 1.8 mM; V(V):L = 1:1.1; T= 25.0 °C, I = 0.10 M (KCl) in 30%
Fig. 8. Concentration distribution curves for the V(V)–STSC system. {cV(V) = 1.8 mM;
V(V):L = 1:1.1; T = 25.0 °C, I = 0.10 M (KCl) in 30% (v/v) DMSO, 60% (v/v) H2O,
10% (v/v) D2O}.
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vanadium binding in these complexes is not sufﬁcient to impact on
the biological activity.
In order to increase the solution stability of vanadium(IV/V)–TSC
complexes, as a next step, STSC, a ligand containing a phenolate oxygen
donor atom instead of the pyridyl nitrogen was investigated in our
studies. The results showed that STSC forms complexes with
oxovanadium(IV) characterized by an (O−,N2,S)-binding mode and a
protonated hydrazinic NHmoiety ([V(IV)O(LH)]+). In addition, species
with a completely deprotonated ligand coordinated through an
(O−,N2,S−) donor set ([V(IV)O(L)] and [V(IV)O(L)(OH)]−) were ob-
served (with V(V) similar species were detected). The stabilities of the
vanadium(IV/V) complexes of STSC were found to be signiﬁcantly
higher than that of the α(N)-pyridyl TSCs. Cytotoxicity measurements
of a STSC–V(V) complex revealed an increase of the anticancer activity
compared to the very low activity of the metal-free STSC ligand. In gen-
eral, the cytotoxic activity of STSC was strongly decreased compared to
α(N)-pyridyl TSCs. Thus STSC derivatives with higher anticancer activ-
ity e.g. terminal dimethylated derivatives will be investigated in subse-
quent studies to further increase the stability and shift the biological
activity to the low micromolar range.
4. Experimental
4.1. Chemicals
Triapine, PTSC, and APTSCwere prepared as described previously [7,
31]. STSC was purchased from Sigma-Aldrich and used without further
puriﬁcation. The exact concentration of the ligand stock solutions
together with the proton dissociation constants was determined by
pH-potentiometric titrations with aid of the computer program
HYPERQUAD [40]. NaVO3, VOSO4, KOH, D2O, and DMSO-d6 were pur-
chased from Sigma-Aldrich and HCl, KCl as well as DMSO were from
Reanal. The V(IV)O stock solution was prepared as described [41] and
standardized for themetal ion concentration by permanganate titration.
Vanadate stock solutionwas prepared by dissolvingNaVO3 in KOH solu-
tion and its concentration was calculated based on mass and total vol-
ume. Double distilled Milli-Q water was used for sample preparations.
All solvents used for synthesis were of analytical grade and used
without further puriﬁcation. V2O4(acac)2 was synthesized according
to literature procedures [32]. Elemental analyses were carried out on a
Carlo Erba microanalyzer at the Microanalytical Laboratory of the Uni-
versity of Vienna. Electrospray ionization mass spectrometry (ESI-MS)
was carried out with a Bruker Esquire 3000 instrument (BrukerDaltonic, Bremen, Germany). Expected and experimental isotope distri-
butionswere compared. UV–vis spectra for the complexeswere record-
ed on a Perkin Elmer Lambda 650 UV–vis spectrophotometer using
samples dissolved in methanol (900–210 nm). 1H and 13C one- and
two-dimensional NMR spectra were recorded in DMSO-d6, with a
Bruker Avance III 500 MHz FT-NMR spectrometer. The residual 1H and
13C present in DMSO-d6 were used as internal references. 51V NMR
spectra for the complexes were recorded in DMSO-d6 with a Bruker
Avance DRX 500 MHz spectrometer. (Abbreviations for NMR data:
py = pyridine, Cq, py = quaternary carbon of pyridine.)
4.2. Synthesis of vanadium(IV/V) complexes of PTSC and APTSC
(2-Formylpyridine N,N-dimethylthiosemicarbazonato)dioxo-
vanadium(V), [V(V)O2(L)] complex of PTSC (1a): PTSC (115 mg,
0.55 mmol) was dissolved in hot methanol (5 mL), added to
V2O4(acac)2 (100 mg, 0.27 mmol) in methanol (5 mL) and the mixture
was stirred for 3 min. The orange precipitate formed was ﬁltered off,
washed with cold methanol (−20 °C) and dried in vacuo. Yield:
118 mg (74%). Anal. Calcd. for C9H11N4O2SV (Mr = 290.22 g/mol):
C, 37.25; H, 3.82; N, 19.31; S, 11.05. Found: C, 37.15; H, 3.68; N, 19.11;
S, 11.20. ESI-MS in methanol (positive): m/z 313, [M + Na]+; 329,
[M + K]+. UV–vis (methanol), λmax, nm (ε, M−1 cm−1):
221 (10,015), 281 (5615), and 490 (6940). 1H NMR (500.10 MHz,
DMSO-d6): δ 8.58 (d, 1H, py, 3JH,H = 4 Hz), 8.54 (s, 1H, HC=N),
8.24 (m, 1H, py), 7.87 (d, 1H, py, 3JH,H = 8 Hz), 7.57 (m, 1H, py),
and 3.27 (s, 6H, N(CH3)2). 13C NMR (125.81 MHz, DMSO-d6):
δ 178.2 (C–S), 154.2 (Cq, py), 153.6 (Cpy), 146.7 (HC=N), 143.5 (Cpy),
125.7 (Cpy), 125.4 (Cpy), and 40.3 (N(CH3)2). 51V NMR (500 MHz,
DMSO-d6): −427.5 ppm. After a few days crystals suitable for X-ray
data collection were directly obtained from the mother liquor.
(3-Amino-2-formylpyridineN,N-dimethylthiosemicarbazonato)dioxo-
vanadium(V), [V(V)O2(L)] complex of APTSC (1b): APTSC (90 mg,
0.40 mmol) was suspended in methanol (4 mL), added to V2O4(acac)2
(73 mg, 0.20 mmol) in methanol (4 mL) and the mixture was stirred
for 1.5 h at room temperature. The dark-red precipitate formed was ﬁl-
tered off, washedwithmethanol and dried in vacuo. Yield: 77mg (63%).
Anal. Calcd. for C9H12N5O2SV (Mr = 305.23 g/mol): C, 35.41; H, 3.96;
N, 22.94; S, 11.05. Found: C, 35.54; H, 3.80; N, 22.63; S, 10.59. ESI-MS
in methanol (positive mode): m/z 329, [M + Na]+; 344, [M + K]+.
UV–vis (methanol), λmax, nm (ε, M−1 cm−1): 257 (3030), 280 (2890),
299sh (2740), and 445 (3560). 1H NMR (500.10 MHz, DMSO-d6): δ
8.89 (s, 1H, HC=N), 7.83 (d, 1H, py, 3JH,H = 5 Hz), 7.36 (dd, 1H, py,
3JH,H = 9 Hz, 4JH,H = 1 Hz), 7.26 (dd, 1H, py, 3JH,H = 9 Hz, 3JH,H =
5 Hz), 6.64 (s, 2H, NH2), and 3.22 (s, 6H, N(CH3)2). 13C NMR
(125.81 MHz, DMSO-d6): δ 176.2 (C–S), 146.2 (HC=N), 145.7 (Cq, py),
142.5 (Cpy), 135.5 (Cq, py), 128.5 (Cpy), 126.9 (Cpy), and
40.3 (N(CH3)2). 51V NMR (500 MHz, DMSO-d6):−430.0 ppm.
(Acetylacetonato(2-formylpyridineN,N-dimethylthiosemicarbazonato)
oxovanadium(IV), [V(IV)O(L)(acac)] complex of PTSC (2a): under an
argon atmosphere, PTSC (79 mg, 0.38 mmol) was added as a solid to a
solution of VO(acac)2 (100 mg, 0.38 mmol) in ethanol (10 mL) and
the mixture was stirred for 1.5 h. The green precipitate formed was ﬁl-
tered off, washed with isopropanol, and dried in vacuo. Yield: 110 mg
(78%). Anal. Calcd. for C14H18N4O3SV (Mr = 373.32 g/mol): C, 45.04;
H, 4.86; N, 15.01; S, 8.59. Found: C, 44.86; H, 4.98; N, 14.72; S, 8.63.
ESI-MS in methanol (positive mode): m/z 396, [M + Na]+; 412,
[M + K]+. UV–vis (methanol), λmax, nm (ε, M−1 cm−1): 268 (10,740),
347sh (3955), and 433 (5930). Crystals suitable for X-ray data collec-
tion were obtained by slow diffusion of ether into a solution of 2a in
dichloromethane under an argon atmosphere.
4.3. Crystallographic structure determination of 1a and 2a
X-ray diffraction measurements were performed on a Bruker X8
APPEXII CCD diffractometer. A single crystal of suitable size was coated
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cooled under a stream of cold N2 maintained by a KRYOFLEX low-
temperature apparatus. Crystals of 1a and 2a were positioned at
35 mm from the detector, and 1820/835 frames were measured, each
for 30/60 s over 1° scan width. The data were processed using SAINT
software [42]. The structureswere solved by directmethods and reﬁned
by full-matrix least-squares techniques. Non-hydrogen atoms were re-
ﬁned with anisotropic displacement parameters. H atoms were placed
at calculated positions and reﬁned as riding atoms in the subsequent
least squares model reﬁnements. The following software programs
and computer were used: structure solution, SHELXS-97 [43]; reﬁne-
ment, SHELXL-97 [43]; molecular diagrams, ORTEP [44]; computer:
Intel CoreDuo. Crystal data and structure reﬁnement details for 1a
and 2a are given in Table S1. Crystallographic data have been deposited
at the Cambridge Crystallographic Data Center with numbers
CCDC1021658 and 1021659.
4.4. pH-potentiometric measurements
The pH-metric measurements for determination of the protonation
constants of the ligands and the overall stability constants of the
V(IV)O complexes were carried out at 25.0 ± 0.1 °C in DMSO:water
30:70 (w/w) as solvent and at an ionic strength of 0.10 M (KCl) in
order to keep the activity coefﬁcients constant. The titrations were per-
formed with carbonate-free KOH solution of known concentration
(0.10 M). The concentrations of the base and the HCl were determined
by pH-potentiometric titrations. An Orion 710A pH-meter equipped
with a Metrohm combined electrode (type 6.0234.100) and a Metrohm
665 Dosimat burette were used for the pH-metric measurements. The
electrode system was calibrated to the pH = − log[H+] scale in the
DMSO/water solvent mixture by means of blank titrations (strong acid
vs. strong base; HCl vs. KOH), similarly to the method suggested by
Irving et al. [45] in pure aqueous solutions. The averagewater ionization
constant, pKw, is 14.52 ± 0.05 in DMSO:water 30:70 (w/w) at 25 °C,
which corresponds well to the literature [8,9,46] and results in
pH 7.26 as neutral pH. The reproducibility of the titration points includ-
ed in the calculations was within 0.005 pH. The pH-metric titrations
were performed in the pH range 2.0–12.6. The initial volume of the sam-
pleswas 10.0mL. The ligand concentrationwas 1 or 2mMandmetal ion
to ligand ratios of 1:1–1:5were used. The acceptedﬁtting of the titration
curves was always less than 0.01 mL. Samples were deoxygenated by
bubbling puriﬁed argon through them for ca. 10 min prior to the mea-
surements. In the case of VIVO-containing samples, argon overpressure
was used when metal ion solution was added to the samples in tightly
closed vessels, which were prior completely deoxygenated by bubbling
a stream of puriﬁed argon through them for ca. 20 min. Argon was also
passed over the solutions during the titrations.
The protonation constants of the ligands were determined with the
computer programHYPERQUAD [40], and PSEQUAD [47]was utilized to
establish the stoichiometry of the complexes and to calculate the stabil-
ity constants (logβ (MpLqHr)) using the literature data for V(IV)O
hydroxido complexes [48]. It is noteworthy that hydrolysis constants
of V(IV)O hydroxido complexes are not known in the literature for the
applied solventmixture. (MpLqHr) is deﬁned for the general equilibrium
pM+ qL+ rH⇌MpLqHr asβ (MpLqHr)= [MpLqHr] / [M]p[L]q[H]r, where
Mdenotes themetal ion (V(IV)O) and L the completely deprotonated li-
gands. In all calculations, exclusively titration data were used from ex-
periments in which no precipitate was visible in the reaction mixture.
4.5. UV–vis spectrophotometric and 51V NMR measurements
A Hewlett Packard 8452A diode array spectrophotometer was used
to record the UV–vis spectra in the interval 260–820 nm. The path
length was 1 cm. Protonation and stability constants and the individual
spectra of the species were calculated by the computer program
PSEQUAD [47]. The spectrophotometric titrations were performed onsamples of the pure TSCs or with V(IV)O; the concentration of ligand
was 50 or 63 μM and the metal-to-ligand ratios were 1:1 and 1:2 over
the pH range between 2 and 12.6 at an ionic strength of 0.10 M KCl in
30% (w/w) DMSO/H2O at 25.0 ± 0.1 °C. For V(IV)O samples, spectra
were recorded under anaerobic conditions.
51V NMR studies were carried out on a Bruker Avance DRX500 in-
strument and a spectral window of 760 ppm, a 90° pulse angle and an
acquisition time of 0.65 s with a relaxation delay of 0.5 s and a pulse
width of 7 ms were used. V(V)OCl3 was used as an external reference.
The TSCs were dissolved in 30% (v/v) DMSO 60% H2O and 10% D2O at
25 °C in a concentration of 1.0 or 1.8 mM and the V(V)O2-to-ligand ra-
tios were 1:1 or 1:1.1. Samples contained 0.10 M KCl. Overall stability
or stepwise constants for the complex formation equilibria were deter-
minedwith the aid of the computer programPSEQUAD [47] on the basis
of the integral values and chemical shifts using the literature data for the
vanadates (H+/V(V)) [49].
4.6. Determination of the distribution coefﬁcient (D)
D7.4 values of PTSC and APTSC were determined by the traditional
shake ﬂask method in n-octanol/buffered aqueous solution at 7.40
(HEPES, 0.01 M) at 25.0 ± 0.2 °C. Measurements and calculations
were performed similarly as we described previously for Triapine and
STSC [25].
4.7. EPR measurements and deconvolution of the spectra
All continuous-wave (CW) EPR spectra were recorded with a
BRUKER EleXsys E500 spectrometer (microwave frequency 9.81 GHz,
microwave power 10 MW, modulation amplitude 5 G, modulation fre-
quency 100 kHz). EPR spectra were recorded at 1.0 mM of V(IV)O and
the metal-to-ligand ratios were 1:1, 1:2, 1:2 and 1:4 for STSC, APTSC,
PTSC, and Triapine, respectively, between pH ~ 2–8 in 30% (w/w)
DMSO/H2O mixture at an ionic strength of 0.10 M KCl. For the
V(IV)O— Triapine, APTSC, PTSC and STSC systems 4, 4, 8 and 5 isotropic
EPR spectra were recorded at room temperature. At higher pH the EPR
signal disappeared possibly because of V(IV)O oxidation, although titra-
tions were carried out under argon atmosphere. Oxidation could be ex-
cluded more efﬁciently in the case of PTSC and spectra of individual
samples could be recorded up to pH 9.8.
At certain pH values, 0.10 mL of samples was taken out of the solu-
tions into quartz EPR tubes and was measured individually in a Dewar
containing liquid nitrogen (at 77 K). KOH solution was added to the
stock solution to change the pH which was measured with an Orion
710A pH-meter equipped with a Metrohm combined electrode
(type 6.0234.100).
Series of V(IV)O CW-EPR spectra recorded at 25 °C were simulated
by the “two-dimensional” method using the 2D_EPR program [50].
The g0, and A0V (I= 7 / 2) oxovanadium(IV) hyperﬁne coupling param-
eters were taken into account to describe each component curve. The
relaxation parameters, α, β, and γ, deﬁned the line widths through the
equation σMI= α+ βMI+ γMI2, where MI denotes themagnetic quan-
tum number of the paramagnetic metal ions.
The anisotropic EPR spectra recorded at 77 Kwere analyzed individ-
uallywith the EPR program [51]. For the V(IV)O complexes gǀǀ, g┴ axial g-
tensor and AǀǀV, A┴V axial hyperﬁne tensor were taken into consideration.
The following expressions are valid for the g values in the case of a dxy
ground state and an axial symmetry:
gII ¼ ge−
8α2β2ξ
ΔE x2; y2ð Þ and g⊥ ¼ ge−
2β2γ2ξ
ΔE xz; y z
  :
Here, α, β, and γ are the vanadium dx2−y2 , dxy, and dxz,yz orbital pop-
ulations, ξ is the spin–orbit constant, ΔE(x2− y2) and ΔE(xz,yz) are the
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and the dxy ground state.
For each spectrum, the noise-corrected regression parameter (Rj
for the jth spectrum) was derived from the average square deviation
(SQD) between experimental and calculated intensities. For the
series of spectra, the ﬁt is characterized by the overall regression
coefﬁcient R, calculated from the overall average SQD. The
details of the statistical analysis were published previously [51].
The hyperﬁne and superhyperﬁne coupling constants and the
relaxation parameters were obtained in ﬁeld units (Gauss = 10−4 T)
and were calculated to 10−4 cm−1 by the correspondence of
A [10−4 cm−1]⬄ 0.4668643 g A [G].
4.8. Cell lines and culture conditions
The following human cell lines were used in this study: the colon
carcinoma cell line SW480 (fromAmerican Type Culture Collection,Ma-
nassas, VA), the ovarian carcinoma cell lineA2780 (fromSigma-Aldrich)
and the epidermal carcinoma-derived cell line KB-3-1 (generously do-
nated by D.W. Shen, Bethesda, USA). All cells were grown in RMPI
1640 supplemented with 10% fetal bovine serum (FCS), with the excep-
tion of SW480 cells with were cultivated in minimal essential medium
with 10% FCS. Cultures were regularly checked for Mycoplasma
contamination.
4.9. MTT assays
To determine cell viability, cells were plated (2 × 103 cells in
100 μL/well) in 96-well plates and allowed to recover for 24 h. Stock so-
lutions (in DMSO) of the test compounds (APTSC, PTSC, STSC, 1a, 2a, 1b)
were diluted in complete culture medium and added to the plates
(100 μL/well). The maximum DMSO content did not exceed 0.5%.
Stock solution of the V(V)–STSC complex was prepared by addition of
NaVO3 inwater to STSC in DMSO at a 1:1metal-to-ligand ratio, followed
by subsequent dilution with cell culture medium. After 72 h drug treat-
ment, the proportion of viable cells was determined by the colorimetric
MTT microculture assay following the manufacturer's recommenda-
tions (EZ4U, Biomedica, Vienna, Austria).
Abbreviations
1a (2-formylpyridine N,N-dimethylthiosemicarbazonato)
dioxovanadium(V)
1b (3-amino-2-formylpyridine N,N-dimethylthiosemicarbazonato)
dioxovanadium(V)
2a (acetylacetonato(2-formylpyridine N,N-dimethylthiosemi-
carbazonato)oxovanadium(IV)
acac acetylacetonate
APTSC 3-aminopyridine-2-carboxaldehyde N,N-dimethylthiosemi-
carbazone
CT charge transfer
CW continuous-wave
δ chemical shift
D7.4 distribution coefﬁcient at pH 7.4
DMSO dimethyl sulfoxide
Dp44mT di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone
ε molar absorptivity
ESI-MS electrospray ionization mass spectrometry
FCS fetal bovine serum
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
MTT 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium
bromide
PTSC pyridine-2-carboxaldehyde N,N-dimethylthiosemicarbazone
SQD average square deviation
SSC salicylaldehyde semicarbazone
STSC salicylaldehyde thiosemicarbazone
TSC thiosemicarbazoneTriapine 3-aminopyridine-2-carboxaldehyde thiosemicarbazone
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